Claudio Fresco, MD - ATBV · Universitaria “Santa Maria della Misericordia” di Udine Traning...
2
CURRENT POSITION Responsabile Scientifico del Dipartimento di Scienze Cardiotoraciche dell’Azienda Ospedaliero- Universitaria “Santa Maria della Misericordia” di Udine Traning VISITING SCENTIST, ISTITUTO DI RICERCHE FARMACOLOGICHE “MARIO NEGRI” 1989-1991 The “Mario Negri” Institute is the Homebase of GISSI Trials. During my permanence in Milan I took active part in the analisys of GISSI 2 Trial, in the design and analisys of the GISSI Avoidable Delay Study and in the design of the GISSI 3 Trial. CARDIOLOGIST, AZIENDA OSPEDALIERO UNIVERITARIA DI UDINE 1991-ACTIVE This is a 1,000 beds Teaching Hospital. The Department of Cardiopulmonary Sciences has a 24/7 primary PCI program, Heart Transplant program, TAVI program. Istruzione Graduated in 1986, School of Medicine, University of Trieste, Italy, Specialist in Cardiology since 1996 Scientific Activity Author or co-author of more than 40 scientific publications and book chapters. The major field of scientific interest is Acute Ischemic heart disease. Scientific Boards Membership Member of the Directing Board of the Working Group on Emergency-Urgency of the ANMCO (Italian National Cardiological Society) (2003-2004), Scientific Consultant of the same Working Group (2005-2008), Member of the Scientific Committe of the ANMCO (2005-2008) (representing the Acute Cardiac Care Working Group) Event Committee Membership: Member of the Critical Event Comittee in the CORE study (international multicentre morbidity/mortality study on Rheothrx in acute MI, published in Circulation 1996), the STARC-2 study (International multicentre study investigating the effects of Trapidil on restenosis after elective PTCA, in press) and the GISSI-HF study (large mortality study investigating omega-3, rosuvastatin, both or neither in patients with chronic congestive heart failure)]. Steering Committee membership: Member of the Steering Committee in the GISSI_Avoidable Delay Study (national survey on pre-hospital delay in MI patients, published in Arch Intern Med 1995), the LATIN Study (national study on the modifications of lipoprotein levels in the acute phase of MI and Unstable Angina, published in Italian Heart Journal), BLITZ-2 Study (national survey on NSTE Coronary syndromes). Has participated in the protocol writing groups in several GISSI substudies and also in the IN-CHF national heart failure Database]. Vice-National Coordinator for ASSENT 3 and ASSENT 3 Plus Studies. National Coordinator for STREAM Trial. Member of the Monitoring Committee for the GISSI-3 and the GISSI Prevenzione Trials (both published , Lancet). Relevant Publications 1. 1. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al. Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction. N Engl J Med. 2013 Mar 10;:130312110331000. 2. Taha Taher, Yuling Fu, Galen S. Wagner, Shaun G. Goodman, Claudio Fresco, Christopher B. Granger, Lars Wallentin, Frans Van de Werf, Freek Verheugt, Paul W. Armstrong. Aborted myocardial infarction Claudio Fresco, MD Udine, Sept 10, 1959
Transcript of Claudio Fresco, MD - ATBV · Universitaria “Santa Maria della Misericordia” di Udine Traning...
CURRENT POSITIONResponsabile Scientifico del Dipartimento di Scienze Cardiotoraciche dell’Azienda Ospedaliero-Universitaria “Santa Maria della Misericordia” di Udine
Traning
VISITING SCENTIST, ISTITUTO DI RICERCHE FARMACOLOGICHE “MARIO NEGRI” 1989-1991
The “Mario Negri” Institute is the Homebase of GISSI Trials. During my permanence in Milan I took active part in the analisys of GISSI 2 Trial, in the design and analisys of the GISSI Avoidable Delay Study and in the design of the GISSI 3 Trial.
CARDIOLOGIST, AZIENDA OSPEDALIERO UNIVERITARIA DI UDINE 1991-ACTIVE
This is a 1,000 beds Teaching Hospital. The Department of Cardiopulmonary Sciences has a 24/7 primary PCI program, Heart Transplant program, TAVI program.
IstruzioneGraduated in 1986, School of Medicine, University of Trieste, Italy, Specialist in Cardiology since 1996
Scientific ActivityAuthor or co-author of more than 40 scientific publications and book chapters.
The major field of scientific interest is Acute Ischemic heart disease.
Scientific Boards Membership Member of the Directing Board of the Working Group on Emergency-Urgency of the ANMCO (Italian National Cardiological Society) (2003-2004), Scientific Consultant of the same Working Group (2005-2008), Member of the Scientific Committe of the ANMCO (2005-2008) (representing the Acute Cardiac Care Working Group)
Event Committee Membership: Member of the Critical Event Comittee in the CORE study (international multicentre morbidity/mortality study on Rheothrx in acute MI, published in Circulation 1996), the STARC-2 study (International multicentre study investigating the effects of Trapidil on restenosis after elective PTCA, in press) and the GISSI-HF study (large mortality study investigating omega-3, rosuvastatin, both or neither in patients with chronic congestive heart failure)].
Steering Committee membership: Member of the Steering Committee in the GISSI_Avoidable Delay Study (national survey on pre-hospital delay in MI patients, published in Arch Intern Med 1995), the LATIN Study (national study on the modifications of lipoprotein levels in the acute phase of MI and Unstable Angina, published in Italian Heart Journal), BLITZ-2 Study (national survey on NSTE Coronary syndromes). Has participated in the protocol writing groups in several GISSI substudies and also in the IN-CHF national heart failure Database]. Vice-National Coordinator for ASSENT 3 and ASSENT 3 Plus Studies. National Coordinator for STREAM Trial. Member of the Monitoring Committee for the GISSI-3 and the GISSI Prevenzione Trials (both published , Lancet).
Relevant Publications
1. 1. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al. Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction. N Engl J Med. 2013 Mar 10;:130312110331000.
2. Taha Taher, Yuling Fu, Galen S. Wagner, Shaun G. Goodman, Claudio Fresco, Christopher B. Granger, Lars Wallentin, Frans Van de Werf, Freek Verheugt, Paul W. Armstrong. Aborted myocardial infarction
Claudio Fresco, MDUdine, Sept 10, 1959
in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. Journal of the American College of Cardiology (2004) vol. 44 (1) pp. 38-43
3. Daniela Miani, Claudio Fresco, Donata Lucci, Maria Cecilia Albanese, Lucio Gonzini, Paolo Maria Fioretti, Aldo P. Maggioni, and Luigi Tavazzi, on behalf of the Italian Survey on Acute Heart Failure InvestigatorsClinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: Results from the Italian Survey on Acute Heart Failure. American Heart Journal (2009) vol. 158 (1) pp. 126-132
4. C Fresco, F Avanzini, S Bosi, M G Franzosi, A P Maggioni, L Santoro, G Bellanti. Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis. GISSI-2 Investigators. Gruppo Italiano per lo Studio della, Sopravvivena nell'Infarto Miocardico. J Hypertens (1996) vol. 14 (6) pp. 743-50
5. A P Maggioni, A Maseri, C Fresco, M G Franzosi, F Mauri, E Santoro, G Tognoni. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med (1993) vol. 329 (20) pp. 1442-8
6. C Fresco, F Carinci, A P Maggioni, A Ciampi, A Nicolucci, E Santoro, L Tavazzi, G Tognoni. Very early assessment of risk for in-hospital death among 11,483 patients with acute myocardial infarction. GISSI investigators. Am Heart J (1999) vol. 138 (6 Pt 1) pp. 1058-64
7. Roberto Latini, Aldo P Maggioni, Giuseppe Peri, Lucio Gonzini, Donata Lucci, Paolo Mocarelli, Luca Vago, Fabio Pasqualini, Stefano Signorini, Dario Soldateschi, Lorenzo Tarli, Carlo Schweiger, Claudio Fresco, Rossana Cecere, Gianni Tognoni, Alberto Mantovani, Lipid Assessment Trial Italian Network (LATIN) Investigatorsl. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation (2004) vol. 110 (16) pp. 2349-54
8. Antonio Di Chiara, Claudio Fresco, Stefano Savonitto, Cesare Greco, Donata Lucci, Lucio Gonzini, Antonio Mafrici, Filippo Ottani, Leonardo Bolognese, Stefano De Servi, Alessandro Boccanelli, Aldo P Maggioni, Francesco Chiarella, BLITZ-2 Investigators. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J (2006) vol. 27 (4) pp. 393-405
9. S Baldasseroni, L De Biase, C Fresco, N Marchionni, M Marini, G Masotti, G Orsini, M Porcu, F Pozzar, M Scherillo, A P Maggioni, Italian Network on Congestive Heart Failure Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). Eur Heart J (2002) vol. 23 (21) pp. 1692-8
10. C. Fresco. Conventional risk factors reconsidered in patients with acute myocardial infarction. Journal of cardiovascular risk (1994) vol. 1 (4) pp. 290-4
11. C. Fresco and A. Proclemer. Clinical challenge. II. Management of recent onset atrial fibrillation. PAFIT-2 Investigators. Eur Heart J (1996) vol. 17 Suppl C pp. 41-7
12. Claudio Fresco, Aldo P Maggioni, Stefano Signorini, Piera A Merlini, Paolo Mocarelli, Gianna Fabbri, Donata Lucci, Marco Tubaro, Marinella Gattone, Carlo Schweiger, LATIN Investigators. Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial. Italian heart journal (2002) vol. 3 (10) pp. 587-92
13. M. G. Franzosi, PhD; C. Fresco, MD; E. Geraci, MD; A. P. Maggioni, MD; L. Tavazzi, MD; G. Tognoni, MD et al. Epidemiology of Avoidable Delay in the Care of Patients With Acute Myocardial Infarction in Italy A GISSI-Generated Study. Arch Intern Med. 1995;155(14):1481-1488.
2
